Log in
NYSE:USNA

USANA Health Sciences Stock Forecast, Price & News

$75.65
-2.98 (-3.79 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$75.04
Now: $75.65
$78.82
50-Day Range
$72.39
MA: $77.40
$85.86
52-Week Range
$43.01
Now: $75.65
$92.26
Volume109,893 shs
Average Volume183,896 shs
Market Capitalization$1.59 billion
P/E Ratio14.01
Dividend YieldN/A
Beta1.03
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More
USANA Health Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
CUSIP90328M10
Phone801-954-7100
Employees1,909

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.06 billion
Cash Flow$5.57 per share
Book Value$16.25 per share

Profitability

Net Income$100.53 million

Miscellaneous

Market Cap$1.59 billion
Next Earnings Date2/2/2021 (Estimated)
OptionableOptionable
$75.65
-2.98 (-3.79 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

How has USANA Health Sciences' stock been impacted by Coronavirus?

USANA Health Sciences' stock was trading at $69.88 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, USNA shares have increased by 8.3% and is now trading at $75.65.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of USANA Health Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for USANA Health Sciences
.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for USANA Health Sciences
.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) posted its earnings results on Tuesday, October, 20th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.29 by $0.15. The business had revenue of $298.50 million for the quarter, compared to analyst estimates of $281.80 million. USANA Health Sciences had a return on equity of 32.87% and a net margin of 10.35%. The firm's revenue was up 14.5% on a year-over-year basis. During the same period last year, the company posted $1.09 earnings per share.
View USANA Health Sciences' earnings history
.

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its board has approved a stock buyback plan on Wednesday, February 5th 2020, which authorizes the company to repurchase $130,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 9.1% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its shares are undervalued.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences updated its FY20 earnings guidance on Tuesday, October, 20th. The company provided EPS guidance of $5.15-5.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.20. The company issued revenue guidance of $1.09-1.115 billion, compared to the consensus revenue estimate of $1.09 billion.

Who are some of USANA Health Sciences' key competitors?

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), The Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the following people:
  • Mr. Kevin G. Guest, Chairman & CEO (Age 57, Pay $1.39M)
  • Mr. Jim Brown, Pres (Age 51, Pay $905.81k)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 50, Pay $641.25k)
  • Mr. Walter Noot, Chief Operating Officer (Age 54, Pay $644.22k)
  • Mr. David Mulham, Chief Sales Officer (Age 60, Pay $678.89k)

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (0.29%), WINTON GROUP Ltd (0.26%), Empowered Funds LLC (0.18%), Assenagon Asset Management S.A. (0.12%), Empirical Finance LLC (0.07%) and Comerica Bank (0.06%). Company insiders that own USANA Health Sciences stock include Brent Neidig, Daniel A Macuga, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot.
View institutional ownership trends for USANA Health Sciences
.

Which institutional investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Alberta Investment Management Corp, First Quadrant L P CA, Comerica Bank, State of Alaska Department of Revenue, and Dupont Capital Management Corp. Company insiders that have sold USANA Health Sciences company stock in the last year include Brent Neidig, Daniel A Macuga, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert A Sinnott, Timothy E Wood, and Walter Noot.
View insider buying and selling activity for USANA Health Sciences
.

Which institutional investors are buying USANA Health Sciences stock?

USNA stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Empirical Finance LLC, Empowered Funds LLC, KBC Group NV, Bowling Portfolio Management LLC, Louisiana State Employees Retirement System, BNP Paribas Arbitrage SA, and WINTON GROUP Ltd. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull, and Myron W Wentz.
View insider buying and selling activity for USANA Health Sciences
.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $75.65.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $1.59 billion and generates $1.06 billion in revenue each year. The company earns $100.53 million in net income (profit) each year or $4.41 on an earnings per share basis. USANA Health Sciences employs 1,909 workers across the globe.

What is USANA Health Sciences' official website?

The official website for USANA Health Sciences is www.usana.com.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.